Literature DB >> 3839579

Bone modulating factors in nephrotic children with normal glomerular filtration rate.

M Freundlich, J J Bourgoignie, G Zilleruelo, A I Jacob, J M Canterbury, J Strauss.   

Abstract

Factors influencing bone and mineral metabolism were evaluated in 16 children with active nephrotic syndrome and normal glomerular filtration rate. All patients were proteinuric and/or hypoalbuminemic and had elevated serum triglyceride and cholesterol levels. Seven patients had never received or had discontinued glucocorticoid treatment at least 6 months before the study; six patients were receiving prednisone at the time of study. Although all patients were hypocalcemic (serum total or ionized calcium), none was hypomagnesemic. Despite the low serum calcium levels, circulating immunoreactive parathyroid hormone was elevated in only nine of 16. Plasma 25-hydroxyvitamin D was low in all 16 patients, averaging 7.6 +/- 1.2 ng/mL for the group. In contrast, levels of 1,25-dihydroxyvitamin D were normal in 12 of 14 patients. Bone mineral content measured by photon absorptiometry averaged 83% and was less than 90% of normal in six of nine patients tested. The findings were not influenced by the recent or concurrent administration of glucocorticoid. The data demonstrate abnormalities of mineral and bone modulation in nephrotic children even in the absence of impaired glomerular filtration rate and irrespective of glucocorticoid therapy. The decrease in serum ionized calcium may be related to an absolute deficiency in 25-hydroxyvitamin D and/or a relative deficiency in 1,25-dihydroxyvitamin D. Undermineralization of bone may result from the low levels of vitamin D metabolites and, in some patients, from an increase in immunoreactive parathyroid hormone. Whether treatment with vitamin D metabolites and/or calcium supplementation will prevent the abnormalities remains to be demonstrated.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3839579

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  9 in total

1.  Bone mineral content in children with nephrotic syndrome.

Authors:  M Freundlich
Journal:  Pediatr Nephrol       Date:  1995-08       Impact factor: 3.714

2.  Vitamin D and Albuminuria in Youth with and without Type 1 Diabetes.

Authors:  Debika Nandi-Munshi; Maryam Afkarian; Kathryn B Whitlock; Jamie L Crandell; Ronny A Bell; Ralph D'Agostino; Sharon Saydah; Amy K Mottl; Dana Dabelea; Mary Helen Black; Elizabeth J Mayer-Davis; Catherine Pihoker
Journal:  Horm Res Paediatr       Date:  2017-05-29       Impact factor: 2.852

3.  Vitamin D insufficiency in steroid-sensitive nephrotic syndrome in remission.

Authors:  Francis L Weng; Justine Shults; Rita M Herskovitz; Babette S Zemel; Mary B Leonard
Journal:  Pediatr Nephrol       Date:  2004-11-25       Impact factor: 3.714

4.  Prophylactic calcium and vitamin D treatments in steroid-treated children with nephrotic syndrome.

Authors:  Mustafa Bak; Erkin Serdaroglu; Rengin Guclu
Journal:  Pediatr Nephrol       Date:  2005-12-29       Impact factor: 3.714

5.  Biochemical bone markers in nephrotic children.

Authors:  Nese Karaaslan Biyikli; Sevinc Emre; Aydan Sirin; Ilmay Bilge
Journal:  Pediatr Nephrol       Date:  2004-06-17       Impact factor: 3.714

6.  Bone histology in steroid-treated children with non-azotemic nephrotic syndrome.

Authors:  Michael Freundlich; Michael Jofe; William G Goodman; Isidro B Salusky
Journal:  Pediatr Nephrol       Date:  2004-02-26       Impact factor: 3.714

7.  Vitamin D in incident nephrotic syndrome: a Midwest Pediatric Nephrology Consortium study.

Authors:  David T Selewski; Ashton Chen; Ibrahim F Shatat; Priya Pais; Larry A Greenbaum; Pavel Geier; Raoul D Nelson; Stefan G Kiessling; Patrick D Brophy; Alejandro Quiroga; Michael E Seifert; Caroline E Straatmann; John D Mahan; Maria E Ferris; Jonathan P Troost; Debbie S Gipson
Journal:  Pediatr Nephrol       Date:  2015-10-23       Impact factor: 3.714

8.  Children with nephrotic syndrome have greater bone area but similar volumetric bone mineral density to healthy controls.

Authors:  R J Moon; R D Gilbert; A Page; L Murphy; P Taylor; C Cooper; E M Dennison; J H Davies
Journal:  Bone       Date:  2013-10-18       Impact factor: 4.398

9.  Association between vitamin D metabolites, vitamin D binding protein, and proteinuria in dogs.

Authors:  Matthew S Miller; Adam J Rudinsky; Brett G Klamer; Dennis J Chew; Valerie J Parker
Journal:  J Vet Intern Med       Date:  2020-10-07       Impact factor: 3.333

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.